Treataware

Two novel immune therapies in early investigation

Immune cells extracted from individuals and then modified to enhance the individual immune response to HIV infection, appear to be a safe and feasible approach to HIV treatment, according to several reports at the XVII International AIDS Conference. In a poster discussion investigators presented data on several immune therapies in early investigational stages of development. Two of these techniques were based on autologous immune cells i.e., immune cells obtained from each individual patient.

http://www.aidsmap.org/en/news/312C77E1-F7C6-42B7-8B7F-978008A1A38C.asp

Our free checklist guide covers the essentials of HIV treatment and care.
Get yours here.

This information was retrieved from the Treataware website (www.treataware.info) on 19 Nov 2008. For further information, please consult the website or call the NAPWA office on 02 8568 0300.